ProQuest Associates IV’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$37.3M Hold
789,297
70.39% 1
2018
Q2
$39.3M Sell
789,297
-306,727
-28% -$15.3M 60.44% 1
2018
Q1
$54.5M Hold
1,096,024
62.61% 1
2017
Q4
$40.8M Sell
1,096,024
-353,721
-24% -$13.2M 54.17% 1
2017
Q3
$45.7M Sell
1,449,745
-1,584
-0.1% -$49.9K 45.77% 1
2017
Q2
$26.2M Buy
+1,451,329
New +$26.2M 33.51% 1